1. Home
  2. TBPH vs SB Comparison

TBPH vs SB Comparison

Compare TBPH & SB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TBPH
  • SB
  • Stock Information
  • Founded
  • TBPH 2013
  • SB 2007
  • Country
  • TBPH United States
  • SB Monaco
  • Employees
  • TBPH N/A
  • SB N/A
  • Industry
  • TBPH Biotechnology: Pharmaceutical Preparations
  • SB Marine Transportation
  • Sector
  • TBPH Health Care
  • SB Consumer Discretionary
  • Exchange
  • TBPH Nasdaq
  • SB Nasdaq
  • Market Cap
  • TBPH 418.7M
  • SB 454.8M
  • IPO Year
  • TBPH N/A
  • SB 2008
  • Fundamental
  • Price
  • TBPH $9.69
  • SB $4.16
  • Analyst Decision
  • TBPH Buy
  • SB
  • Analyst Count
  • TBPH 4
  • SB 0
  • Target Price
  • TBPH $13.75
  • SB N/A
  • AVG Volume (30 Days)
  • TBPH 191.3K
  • SB 514.3K
  • Earning Date
  • TBPH 11-12-2024
  • SB 11-13-2024
  • Dividend Yield
  • TBPH N/A
  • SB 4.69%
  • EPS Growth
  • TBPH N/A
  • SB 35.10
  • EPS
  • TBPH N/A
  • SB 0.90
  • Revenue
  • TBPH $63,192,000.00
  • SB $318,430,000.00
  • Revenue This Year
  • TBPH $6.93
  • SB $9.46
  • Revenue Next Year
  • TBPH $45.31
  • SB N/A
  • P/E Ratio
  • TBPH N/A
  • SB $4.89
  • Revenue Growth
  • TBPH 15.93
  • SB 10.27
  • 52 Week Low
  • TBPH $7.44
  • SB $3.45
  • 52 Week High
  • TBPH $11.71
  • SB $6.33
  • Technical
  • Relative Strength Index (RSI)
  • TBPH 70.66
  • SB 37.31
  • Support Level
  • TBPH $9.38
  • SB $4.31
  • Resistance Level
  • TBPH $10.10
  • SB $4.49
  • Average True Range (ATR)
  • TBPH 0.32
  • SB 0.13
  • MACD
  • TBPH 0.11
  • SB 0.01
  • Stochastic Oscillator
  • TBPH 83.26
  • SB 22.61

About TBPH Theravance Biopharma Inc.

Theravance Biopharma Inc is a diversified biopharmaceutical company focused on the discovery, development, and commercialization of organ-selective medicines. Its purpose is to pioneer a new generation of small-molecule drugs designed to better meet patient needs. Its research is focused on the areas of inflammation and immunology. The firm applies organ-selective expertise to target disease biologically, to discover and develop medicines that may expand the therapeutic index with the goal of maximizing efficacy and limiting systemic side effects. The company develops lung-selective medicines to treat respiratory disease, including FDA-approved YUPELRI (revefenacin) inhalation solution indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD).

About SB Safe Bulkers Inc ($0.001 par value)

Safe Bulkers Inc is an international provider of marine drybulk transportation services, transporting bulk cargoes, particularly coal, grain and iron ore, along international shipping routes for consumers of marine drybulk transportation services. The company employs its vessels on both period time charters and spot time charters, according to the assessment of market conditions, with consumers of marine drybulk transportation services.

Share on Social Networks: